LifeNet Health’s ViviGen MIS optimizes leading cellular allograft for minimally invasive procedures
LifeNet Health’s ViviGen MIS optimizes leading cellular allograft for minimally invasive procedures
Boston, Mass. (Sept. 28, 2021) — LifeNet Health, the world leader in allograft biologics, has optimized its industry-leading cellular bone matrix for minimally invasive surgery with the launch of ViviGen® MIS Delivery System, a major improvement in precision, efficiency and reliability over traditional bone-graft delivery.
placental membrane for wound healing. Currently in limited release with select surgeons in the U.S., Matrion will be available nationally in early 2021.
medicine, today opened a technologically advanced logistics and distribution center in Indianapolis. This state-of-the-art facility adds unmatched reliability and on-demand, just-in-time delivery capabilities to patients and hospitals around the world.